dabigatran etexilate
Generic: dabigatran etexilate
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
dabigatran etexilate
Generic Name
dabigatran etexilate
Labeler
aurobindo pharma limited
Dosage Form
CAPSULE
Routes
Active Ingredients
dabigatran etexilate mesylate 110 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59651-974
Product ID
59651-974_4b36f34b-c19b-497d-9dd6-5c50404226c5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208039
Listing Expiration
2026-12-31
Marketing Start
2025-05-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59651974
Hyphenated Format
59651-974
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dabigatran etexilate (source: ndc)
Generic Name
dabigatran etexilate (source: ndc)
Application Number
ANDA208039 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 110 mg/1
Packaging
- 60 CAPSULE in 1 BOTTLE (59651-974-60)
- 10 BLISTER PACK in 1 CARTON (59651-974-61) / 6 CAPSULE in 1 BLISTER PACK
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4b36f34b-c19b-497d-9dd6-5c50404226c5", "openfda": {"upc": ["0359651974605"], "unii": ["SC7NUW5IIT"], "rxcui": ["1037045", "1037179", "1723476"], "spl_set_id": ["5b196b1f-408e-4615-b980-9f822adff835"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (59651-974-60)", "package_ndc": "59651-974-60", "marketing_start_date": "20250514"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (59651-974-61) / 6 CAPSULE in 1 BLISTER PACK", "package_ndc": "59651-974-61", "marketing_start_date": "20250514"}], "brand_name": "DABIGATRAN ETEXILATE", "product_id": "59651-974_4b36f34b-c19b-497d-9dd6-5c50404226c5", "dosage_form": "CAPSULE", "pharm_class": ["Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "59651-974", "generic_name": "DABIGATRAN ETEXILATE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DABIGATRAN ETEXILATE", "active_ingredients": [{"name": "DABIGATRAN ETEXILATE MESYLATE", "strength": "110 mg/1"}], "application_number": "ANDA208039", "marketing_category": "ANDA", "marketing_start_date": "20250514", "listing_expiration_date": "20261231"}